Itau Unibanco Holding S.A.’s Syndax Pharmaceuticals SNDX Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,423	Closed	-$13K	–	627
2019 Q2	$13K	Sell	1,423 -1,205	-46%	-$8.78K	﹤0.01%	580
2019 Q1	$11K	Hold	2,628	–	–	﹤0.01%	574
2018 Q4	$11K	Buy	2,628 +240	+10%	+$1.32K	﹤0.01%	574
2018 Q3	$19K	Sell	2,388 -868	-27%	-$6.19K	﹤0.01%	572
2018 Q2	$23K	Sell	3,256 -25	-0.8%	-$245	﹤0.01%	663
2018 Q1	$47K	Buy	3,281 +2,329	+245%	+$24.7K	﹤0.01%	483
2017 Q4	$8K	Buy	952 +204	+27%	+$2.02K	﹤0.01%	528
2017 Q3	$28K	Sell	748 -1,893	-72%	-$23.2K	﹤0.01%	608
2017 Q2	$37K	Buy	2,641 +2,380	+912%	+$27.2K	﹤0.01%	326
2017 Q1	$4K	Buy	+261	New	+$2.71K	﹤0.01%	656

Other funds holding SNDX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Itau Unibanco Holding S.A.'s SNDX Position: Q3 2019 in Review

Itau Unibanco Holding S.A. sold out of Syndax Pharmaceuticals (SNDX) in Q3 2019, closing a stake of 1,423 shares — an estimated $13K sold.

Itau Unibanco Holding S.A. first reported a position in SNDX in Q1 2017 and held it in 10 quarters. The position peaked at $47K in Q1 2018. 72 funds tracked by Wall St. Rank hold SNDX as of Q3 2019.

Itau Unibanco Holding S.A. reported no remaining Syndax Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 1,423 Syndax Pharmaceuticals shares in Q3 2019, an estimated $13K.
Itau Unibanco Holding S.A. first reported a position in Syndax Pharmaceuticals in Q1 2017 and held it in 10 quarters.
Itau Unibanco Holding S.A.'s Syndax Pharmaceuticals position peaked at $47K in Q1 2018.
72 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2019, filed 14 Nov 2019.